Bluestar Adisseo Company

Equities

600299

CNE000001253

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-04-17 pm EDT 5-day change 1st Jan Change
9.04 CNY -0.33% Intraday chart for Bluestar Adisseo Company -1.31% +13.00%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bluestar Adisseo's 2023 Profit Plummets 96% MT
Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Bluestar Adisseo Company Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Bluestar Adisseo to Invest 4.9 Billion Yuan Into Methionine Production Base MT
Bluestar Adisseo Company Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Bluestar Adisseo Co., Ltd. Announces Executive Changes CI
Bluestar Adisseo Co., Ltd Announces Board Changes CI
Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Bluestar Adisseo Logs Over 15% Drop in 2022 Profit MT
Bluestar Adisseo Company Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
UBS Upgrades Bluestar Adisseo to Buy From Neutral, Adjusts Price Target to 13 Yuan From 14.2 Yuan MT
Bluestar Adisseo Company Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Bluestar Adisseo Company(SHSE:600299) dropped from Shanghai Stock Exchange Health Care Sector Index CI
Bluestar Adisseo Company Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
Calysta, Inc. announced that it has received $39 million in funding from BP Ventures Limited, Bluestar Adisseo Company, A-Spark Good Ventures, Westech Investment Advisors, Inc. CI
Bluestar Adisseo Company Reports Earnings Results for the Half Year Ended June 30, 2021 CI
Bluestar Adisseo Company Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Bluestar Adisseo Company Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Calysseo, A Joint Venture Between Adisseo and Calysta, Buildis First Facility in Chongqing, China CI
GRAIN HIGHLIGHTS : Top Stories of the Day DJ
LIVESTOCK HIGHLIGHTS : Top Stories of the Day DJ
Bluestar Adisseo Company acquired FraMelco B.V. from a family. CI
Chart Bluestar Adisseo Company
More charts
Bluestar Adisseo Co is a China-based company principally engaged in the research, design, production and distribution of additives for animal nutrition. The Company’s products include functional products, special products and others. Its functional products include methionine, vitamins, ammonia sulfates, as well as sodium sulfates, among others. Its special products include enzyme preparations, organic selenium additives and others. The Company also provides carbon disulfide, sulfuric acid and preparation services. The Company operates its business in domestic and overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
9.04 CNY
Average target price
9.81 CNY
Spread / Average Target
+8.52%
Consensus
  1. Stock Market
  2. Equities
  3. 600299 Stock
  4. News Bluestar Adisseo Company
  5. UBS Upgrades Bluestar Adisseo to Buy From Neutral, Adjusts Price Target to 13 Yuan From 14.2 Yuan